Skip to main content

Bellerophon Therapeutics, Inc.

BLPHDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001600132

Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Bellerophon Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Bellerophon Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Bellerophon Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Puissance Capital Management LP10% Owner0Oct 16, 20230
Wang Theodore T10% Owner0Oct 16, 20230
Puissance Capital Fund (GP) LLC10% Owner0Oct 16, 20230
Puissance Life Science Opportunities Fund VI10% Owner0Oct 16, 20230
Bruder Scott PDirector–Jun 9, 20230
Fernandes PeterSee Remarks22,515Jun 9, 20230
Dekker MartinSee Remarks17,666Jun 9, 20230
Amin NaseemDirector291,865Jun 9, 20230
Cloyd Mary AnnDirector–Jun 9, 20230
Shah Parag SureshVP of Business Operations17,666Jun 9, 20230
Teufel CrispinDirector–Jun 9, 20230
Kim BobaeVP Reg. Affairs & Quality1,723Jun 9, 20230
Laccona NicholasFINANCIAL OFFICER, (PFO & PAO)12,470Feb 14, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 19, 2023 (view filing)8:55 PM ETMay 181 dayWang Theodore T and 3 othersDirector, 10% OwnerSSale−560.0K$9.46−$5.30M−31.6%1.21M after
May 22, 2023 (view filing)May 184 daysKim BobaeVP Reg. Affairs & QualitySSale−9.46K$10.00−$94.5K−84.6%1.72K after
Jun 7, 2023 (view filing)9:21 PM ETJun 7Same dayWang Theodore T and 3 othersDirector, 10% OwnerSSale−134.4K$0.83−$111.6K−11.1%1.08M after
Oct 16, 2023 (view filing)8:51 PM ETOct 133 daysPuissance Capital Management LP and 3 others10% OwnerSSale−1.08M$0.1038−$111.8K−100.0%0 after